p38α MAPK is required for contact inhibition

被引:0
|
作者
Dagmar Faust
Ignacio Dolado
Ana Cuadrado
Franz Oesch
Carsten Weiss
Angel R Nebreda
Cornelia Dietrich
机构
[1] Institute of Toxicology,
[2] Johannes Gutenberg-University,undefined
[3] CNIO (Spanish National Cancer Center),undefined
来源
Oncogene | 2005年 / 24卷
关键词
contact inhibition; p38 MAPK; fibroblasts;
D O I
暂无
中图分类号
学科分类号
摘要
Proliferation of nontransformed cells is regulated by cell–cell contacts, which are referred to as contact-inhibition. Despite its generally accepted importance for cell cycle control, knowledge about the intracellular signalling pathways involved in contact inhibition is scarce. In the present work we show that p38α mitogen-activated protein kinase (MAPK) is involved in the growth-inhibitory signalling cascade of contact inhibition in fibroblasts. p38α activity is increased in confluent cultures of human fibroblasts compared to proliferating cultures. Time course studies show a sustained activation of p38α in response to cell–cell contacts in contrast to a transient activation after serum stimulation. The induction of contact inhibition by addition of glutaraldehyde-fixed cells is impaired by pharmacological inhibition of p38 as well as in p38α−/− fibroblasts. Further evidence for a central role of p38α in contact inhibition comes from the observation that p38α−/− fibroblasts show a higher saturation density compared to wild-type (wt) fibroblasts, which is reversed by reconstituted expression of p38α. In agreement with a defect in contact inhibition, p27Kip1 accumulation is impaired in p38α−/− fibroblasts compared to wt fibroblasts. Hence, our work shows a new role for p38α in contact inhibition and provides a mechanistic basis for the recently proposed tumour suppressive function of this MAPK pathway.
引用
收藏
页码:7941 / 7945
页数:4
相关论文
共 50 条
  • [21] Inhibition of p38 MAPK in the brain through nasal administration of p38 inhibitor loaded in chitosan nanocapsules
    Casadome-Perales, Alvaro
    De Matteis, Laura
    Alleva, Maria
    Infantes-Rodriguez, Cristina
    Palomares-Perez, Irene
    Saito, Takashi
    Saido, Takaomi C.
    Esteban, Jose A.
    Nebreda, Angel R.
    de la Fuente, Jesus M.
    Dotti, Carlos G.
    [J]. NANOMEDICINE, 2019, 14 (18) : 2409 - 2422
  • [22] p38 MAPK activation is required for esculetin-induced inhibition of vascular smooth muscle cells proliferation
    Yun, Eun-Sun
    Park, Sung-Suk
    Shin, Ho-Chul
    Choi, Yung Hyun
    Kim, Wun-Jae
    Moon, Sung-Kwon
    [J]. TOXICOLOGY IN VITRO, 2011, 25 (07) : 1335 - 1342
  • [23] The p38 MAPK pathway is required for cell growth inhibition of human breast cancer cells in response to activin
    Cocolakis, E
    Lemay, S
    Ali, S
    Lebrun, JJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (21) : 18430 - 18436
  • [24] Inhibition of p38 MAPK signaling promotes late stages of myogenesis
    Weston, AD
    Sampaio, AV
    Ridgeway, AG
    Underhill, TM
    [J]. JOURNAL OF CELL SCIENCE, 2003, 116 (14) : 2885 - 2893
  • [25] p38 alpha MAPK is not required for the loss of intercellular adhesion in pemphigus vulgaris
    Mao, X.
    Sano, Y.
    Park, J. M.
    Payne, A. S.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S36 - S36
  • [26] p38 MAPK inhibition alleviates experimental acute pancreatitis in mice
    Ming-Hua Cao
    Jing Xu
    Hai-Dong Cai
    Zhong-Wei Lv
    Ya-Jing Feng
    Kun Li
    Chun-Qiu Chen
    Yong-Yu Li
    [J]. Hepatobiliary & Pancreatic Diseases International, 2015, 14 (01) : 101 - 106
  • [27] p38 MAPK is required for the antitumor activity of the vascular disrupting agent DMXAA
    Lou, Liguang
    Wu, Qiong
    Quan, Haitian
    Xu, Yongping
    [J]. CANCER RESEARCH, 2012, 72
  • [28] Inhibition of p38 MAPK attenuates vascular proliferation in pulmonary hypertension
    Shimamoto, A
    Lu, J
    Shimpo, H
    Chong, AJ
    Hampton, CR
    Yada, M
    Yada, I
    Pohlman, TH
    Verrier, ED
    [J]. CIRCULATION, 2003, 108 (17) : 271 - 271
  • [29] p38 MAPK inhibition alleviates experimental acute pancreatitis in mice
    Cao, Ming-Hua
    Xu, Jing
    Cai, Hai-Dong
    Lv, Zhong-Wei
    Feng, Ya-Jing
    Li, Kun
    Chen, Chun-Qiu
    Li, Yong-Yu
    [J]. HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2015, 14 (01) : 101 - 106
  • [30] Novel Antiplatelet Activity of Minocycline Involves Inhibition of p38 MAPK
    Jackson, J. W.
    Singh, M., V
    Davidson, G. A.
    Schifitto, G.
    Maggirwar, S. B.
    [J]. JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2015, 10 : S76 - S76